In the annual general meeting, Vu Thi Thuan, chair of management board in Traphaco Joint Stock Co (coded TRA) released the company’s strategic development plan up to 2015, in which the company aims to maintain annual growth rates of 20-25 percent in both revenue and profit. This year, the company plans to reach total revenue of 1.33 trillion dong and after tax profit of 130 billion dong, up 46 percent against 2011.
Traphaco would pay 2012 dividend at 20 percent in cash.
In 2011, most of the company’s sales revenue came from domestic markets, especially in northern delta region (43 percent). The company’s export accounted for minor quantity, mainly to markets of Ukraine, Belgium.
In the coming years, Traphaco would plan to introduce traditional herbal medicine to other countries in the world so as to expand the export markets. Apart from maintaining the market shares for traditional products, the company expects to release six new products, set up cooperation relationship with foreign partners and become the sole distributor for at least two imported products.